Page 15 - Cassava Sciences News Today

The campus of City College of New York. A scientist who advises Cassava Sciences , a biotech under investigation by the Securities and Exchange Commission,…

Shares of Cassava Sciences, Inc. (SAVA) are plunged more than 20 percent on Friday morning trade after the company said a report prepared by City University of New York was leaked to the press, which was preceded by a 40 percent increase in short-selling activity.

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.

Science reports that an investigation accuses neuroscientist who often worked with Cassava of 'scientific misconduct' across multiple papers.

Corporate Overview October 2023 Forward-Looking Statements & Safe Harbor This presentation from Cassava Sciences contains...

Cassava bounced back from hitting a 52-week low to start the week.

Cassava Sciences (SAVA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy...

804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical TrialA Second Pivotal Phase 3 Clinical Trial Is Expected to Complete Enrollment Q4 2023, With a Target Enrollment of Approximately...

Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $16.41 and last traded at $16.54, with a volume of 122449 shares traded. The stock had previously closed at $16.64. Analysts Set New Price Targets Separately, HC Wainwright reiterated […]

Cassava Sciences, Inc. (NASDAQ:SAVA – Get Free Report) shares were up 5.3% on Wednesday . The stock traded as high as $19.18 and last traded at $19.17. Approximately 525,500 shares were traded during mid-day trading, a decline of 45% from the average daily volume of 962,936 shares. The stock had previously closed at $18.20. Wall […]